We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Titan Pharmaceuticals Inc | NASDAQ:TTNP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0401 | -0.59% | 6.8099 | 6.55 | 6.81 | 6.81 | 6.60 | 6.81 | 1,448 | 16:54:10 |
| | |
Per Unit
|
| |
Total
|
| ||||||
Public offering
|
| | | $ | 0.225 | | | | | $ | 9,000,000 | | |
Underwriting discounts and commissions(1)
|
| | | $ | 0.01575 | | | | | $ | 630,000 | | |
Proceeds to us, before expenses
|
| | | $ | 0.20925 | | | | | $ | 8,370,000 | | |
Description
|
| |
Page
|
| |||
| | | | 1 | | | |
| | | | 7 | | | |
| | | | 24 | | | |
| | | | 25 | | | |
| | | | 26 | | | |
| | | | 27 | | | |
| | | | 30 | | | |
| | | | 33 | | | |
| | | | 33 | | | |
| | | | 33 | | | |
| | | | 34 | | |
|
Public offering price per unit
|
| | | | | | | | | $ | 0.225 | | |
|
Net tangible book value per share as of June 30, 2019
|
| | | $ | (0.04) | | | | | | | | |
|
Increase in net tangible book value per share after this offering
|
| | | | 0.179 | | | | | | | | |
|
As adjusted net tangible book value per share after this offering
|
| | | | | | | | | | 0.139 | | |
|
Dilution per share to new investors
|
| | | | | | | | | $ | (0.086) | | |
Underwriter
|
| |
Number of Units
|
| |||
Maxim Group LLC
|
| | | | 40,000,000 | | |
Total
|
| | | | 40,000,000 | | |
| | |
Per Unit
|
| |
Total
(No Exercise) |
| |
Total
(Full Exercise in shares only) |
| |||||||||
Public offering price
|
| | | $ | 0.225 | | | | | $ | 9,000,000 | | | | | $ | 10,350,000 | | |
Underwriting discounts and commissions
|
| | | $ | 0.01575 | | | | | $ | 630,000 | | | | | $ | 724,500 | | |
Proceeds, before expenses, to us
|
| | | $ | 0.20925 | | | | | $ | 8,370,000 | | | | | $ | 9,625,500 | | |
1 Year Titan Pharmaceuticals Chart |
1 Month Titan Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions